🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, phase 1 trial evaluating the safety of oncolytic ade...
Status
Active Not Recruiting
Location
National Center for Cancer Immune Therapy Herlev Hospital, Copenhagen University
Start Date
2025-06-25
Trial ID
NCT06961786
Treatments Being Tested
This is an open-label, phase 1/1b, dose-escalation, multicenter and multina...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2022-05-17
Trial ID
NCT05271318
Treatments Being Tested
This is an open label, Phase 1, dose escalation trial evaluating the safety...
Status
Active Not Recruiting
Location
Hoag Memorial Hospital Presbyterian
Start Date
2024-07-23
Trial ID
NCT06125197
This is an open-label, phase 1, first-in-human (FIH), dose-escalation, mult...
Status
Completed
Location
National Center for Cancer Immune Therapy Herlev Hospital, Copenhagen University
Start Date
2020-02-26
Trial ID
NCT04217473
Treatments Being Tested
This is an open-label, phase 1, dose-escalation, multicenter trial evaluati...
Status
Completed
Location
Helsinki University Hospital
Start Date
2021-01-11
Trial ID
NCT04695327
Treatments Being Tested
This is a phase 1, dose-escalation trial evaluating the safety of oncolytic...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2023-03-08
Trial ID
NCT05222932